ArticleTheranostics2019

DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.

Tangliang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.